Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD

References

• Chang MY, Ong AC. Autosomal dominant polycystic kidney disease: Recent advances in pathogenesis and treatment. Nephron Physiol. 2008;108:1–7
   Web of Science ®Google Scholar
• Bogdanova N, Markoff A, Horst J. Autosomal dominant polycystic kidney disease – Clinical and genetic aspects. Kidney Blood Press Res. 2002;25:265–283
   PubMed Web of Science ®Google Scholar
• Driscoll JA, Bhalla S, Liapis H, Ibricevic A, Brody SL. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest. 2008;133:1181–1188
   PubMed Web of Science ®Google Scholar
• Mao Z, Xie G, Ong AC. Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2015;30:197–203
   PubMed Web of Science ®Google Scholar
• Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet. 1994;343:824–827
   PubMed Web of Science ®Google Scholar
• Mosetti MA, Leonardou P, Motohara T, Kanematsu M, Armao D, Semelka RC. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques. J Magn Reson Imaging. 2003;18:210–215
   PubMed Web of Science ®Google Scholar
• Pei Y, Watnick T. Diagnosis and screening of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010;17:140–152
   PubMed Web of Science ®Google Scholar
• Chapman AB, Guay-Woodford LM, Grantham JJ, et al. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int. 2003;64:1035–1045
   PubMed Web of Science ®Google Scholar
• Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Sutherland S. Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years. Am J Kidney Dis. 1990;15:237–243
   PubMed Web of Science ®Google Scholar
• Rutkowski B, Lichodziejewska-Niemierko M, Grenda R, Czekalski S, Durlik M, Bautembach S. Report on the Renal Replacement Therapy in Poland-2007. Gdańsk: Drukonsul; 2009
   Google Scholar
• Chapman AB. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol. 2008;3:1197–1204
   PubMed Web of Science ®Google Scholar
• Masoumi A, Elhassan E, Schrier RW. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications. Iran J Kidney Dis. 2011;5:1–8
   PubMedGoogle Scholar
• Grantham JJ, Cook LT, Torres VE, et al. Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int. 2008;73:108–116
   PubMed Web of Science ®Google Scholar
• King BF, Reed JE, Bergstralh EJ, Sheedy PF II, Torres VE. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000;11:1505–1511
   PubMed Web of Science ®Google Scholar
• Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis. 2002;39:1127–1134
   PubMed Web of Science ®Google Scholar
• Grantham JJ, Torres VE, Chapman AB, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006:354:2122–2130
   PubMed Web of Science ®Google Scholar
• Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease; early occurrence and unique aspects. J Am Soc Nephrol. 2001;12:194–200
   PubMed Web of Science ®Google Scholar
• Gabow PA, Chapman AB, Johnson AM, et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990;38:1177–1180
   PubMed Web of Science ®Google Scholar
• Sans Atxer L, Roca-Cusachs A, Torra R, et al. Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure. Nefrologia. 2010;30:567–572
   PubMed Web of Science ®Google Scholar
• WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO; 1999
   Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
   PubMed Web of Science ®Google Scholar
• Sienz M, Ignee A, Dietrich CF. Sonography today: Reference values in abdominal ultrasound: Aorta, inferior vena cava, kidneys. Z Gastroenterol. 2012;50:293–315
   PubMed Web of Science ®Google Scholar
• Cheong B, Muthupillai R, Rubin MF, Flamm SD. Normal values for renal length and volume as measured by magnetic resonance imaging. Clin J Am Soc Nephrol. 2007;2:38–45
   PubMed Web of Science ®Google Scholar
• Miletić D, Fuckar Z, Sustić A, Mozetic V, Stimac D, Zauhar G. Sonographic measurement of absolute and relative renal length in adults. J Clin Ultrasound. 1998;26:185–189
   PubMed Web of Science ®Google Scholar
• Pietrzak-Nowacka M, Safranow K, Czechowska M, Dutkiewicz G, Kornacewicz-Jach Z, Ciechanowski K. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner. Kidney Blood Press Res. 2012;36:301–309
   PubMed Web of Science ®Google Scholar
• Nicolau C, Torra R, Bianchi L, et al. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound. 2000;28:277–282
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Meyer C, Mitrakou A, Gerich JE. Important role of the kidney in human carbohydrate metabolism. Med Hypotheses. 1999;52:363–366
   PubMed Web of Science ®Google Scholar
• Fiorini F, Raffa M, Patrone E, Castelluccio A. Glucose metabolism and chronic renal insufficiency. Arch Ital Urol Androl. 1994;66:51–56
   PubMedGoogle Scholar
• Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975;55:1278–1283
   PubMed Web of Science ®Google Scholar
• Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41:368–377
   PubMed Web of Science ®Google Scholar
• Pietrzak-Nowacka M, Safranow K, Byra E, Nowosiad M, Marchelek-Myśliwiec M, Ciechanowski K. Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease. Scand J Clin Lab Invest. 2010;70:561–567
   PubMed Web of Science ®Google Scholar
• Rowe I, Chiaravalli M, Mannella V, et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med. 2013;19:488–493
   PubMed Web of Science ®Google Scholar
• Pabico RC, McKenna BA, Freeman RB. Renal tubular dysfunction in patients with cystic disease of the kidneys. Urology. 1998;51:156–160
   PubMed Web of Science ®Google Scholar
• Torres VE, Keith DS, Offord KP, Kon SP, Wilson DM. Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int. 1994;45:1745–1753
   PubMed Web of Science ®Google Scholar
• Wołyniec W, Jankowska MM, Król E, Czarniak P, Rutkowski B. Current diagnostic evaluation of autosomal dominant polycystic kidney disease. Pol Arch Med Wewn. 2008;118:767–773
   PubMedGoogle Scholar
• Gómez PF, García-Cosmes P, Becerra LG, Romo JM. Clinical analysis of a population with autosomal dominant polycystic kidney disease. Nefrologia. 2010;30:87–94
   PubMed Web of Science ®Google Scholar